We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLPX
2651
DELISTED
Olaplex Holdings
OLPX
-698
Closed -$1.64K
OMCL icon
2652
Omnicell
OMCL
$1.68B
-21
Closed -$916
ACH
2653
Accendra Health
ACH
$253M
-12
Closed -$189
OPCH icon
2654
Option Care Health
OPCH
$3.5B
-32
Closed -$1K
OPK icon
2655
Opko Health
OPK
$985M
-261
Closed -$389
OPTN
2656
DELISTED
OptiNose
OPTN
-11
Closed -$113
OTTR icon
2657
Otter Tail
OTTR
$3.84B
-114
Closed -$8.91K
OUT icon
2658
Outfront Media
OUT
$5.62B
-361
Closed -$6.53K
PANL icon
2659
Pangaea Logistics
PANL
$483M
-765
Closed -$5.53K
PARR icon
2660
Par Pacific Holdings
PARR
$4.14B
-612
Closed -$10.8K
PBF icon
2661
PBF Energy
PBF
$7.84B
-1,072
Closed -$33.2K
PCRX icon
2662
Pacira BioSciences
PCRX
$1.06B
-42
Closed -$633
PD icon
2663
PagerDuty
PD
$852M
-101
Closed -$1.87K
PDFS icon
2664
PDF Solutions
PDFS
$2.14B
-23
Closed -$729
PEBO icon
2665
Peoples Bancorp
PEBO
$1.49B
-91
Closed -$2.74K
PEPG icon
2666
PepGen
PEPG
$131M
-76
Closed -$650
PGEN icon
2667
Precigen
PGEN
$2.36B
-690
Closed -$654
PHAT icon
2668
Phathom Pharmaceuticals
PHAT
$691M
-17
Closed -$308
PHIN icon
2669
Phinia Inc
PHIN
$2.89B
-13
Closed -$599
PIII icon
2670
P3 Health Partners
PIII
$33.6M
-5
Closed -$100
PINE
2671
Alpine Income Property Trust
PINE
$331M
-91
Closed -$1.66K
PKOH icon
2672
Park-Ohio Holdings
PKOH
$590M
-7
Closed -$215
PLYM
2673
DELISTED
Plymouth Industrial REIT
PLYM
-2
Closed -$46
POWL icon
2674
Powell Industries
POWL
$7.74B
-18
Closed -$1.33K
PRLD icon
2675
Prelude Therapeutics
PRLD
$355M
-19
Closed -$40

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.